Abstract
This review enumerates and discusses the elements involved in the control of human blood pressure via a historical evolutionary form. The older and most recent element literature presentations were researched using MEDLINE and a manual review of documents cited. Independent data extraction and cross-referencing was performed. Of the 28 known elements that can influence blood pressure, 15 were found to be involved in human blood pressure regulation. The elements were divided into four groups: electrolyte, composed of sodium, potassium, calcium, and magnesium; metal, which included zinc, copper, and iron; toxic, made up of lead, mercury, cadmium, barium, thallium, arsenic; miscellaneous (lithium and selenium). Evolutionary historical data, possible mechanisms of actions, and interactions between elements that have been shown to influence blood pressure are discussed. Controversy exists over the therapeutic use of elements to alter blood pressure but is absent in the case of the toxic group where preventive control is a proven public health matter. The significance of these 15 elements in the regulation of human blood pressure has been established and ongoing studies will continue to reinforce their influence and importance.
Similar content being viewed by others
References
H. F. Loyke, Effects of elements on blood pressure, Biol. Trace Element Res. 58, 1–11 (1997).
L. Ambord, and E. Beaujard, Causes de l’hypertension anterielle, Arch. Gen. Med. 1, 520–533 (1904).
W. Kempner, Treatment of kidney disease and hypertensive vascular disease with rice diet, NC Med. J. 5, 125–133 (1944).
F. C. Luft and M. H. Weinberger, Sodium intake and essential hypertension, Hypertension 4(Suppl. III), 14–19 (1982).
L. B. Page, A. Damon, and R. C. Moellering, Jr., Anticedents of cardiovascular disease in six Solomon Islands societies, Circulation 49, 1132–1146 (1974).
M. Reusser, D. McCarron, Micronutrient Effects on Blood Pressure Regulation. Nutrt. Rev, 52, 367–75 (1994).
N. Groudal, A. Galloc, and P. Gerred, Effects of sodium restriction on blood pressure, renin, aldosterone, catacholamine and trygliceride, JAMA 279(17), 1383–1389 (1998).
F. Cappuccio, N. Murkandu, C. Carney, et al., Double-blind study randomized trial of modest salt restriction in older people, Lancet 350, 850–854 (1997).
P. Friberg, I. Meredith, G. Jennings, G. Lambert, V. Fazio, and M. Esler, Evidence for increased renal norepinephrine overflow during sodium restriction in humans, Hypertension 16, 121–130 (1990).
F. H. Messerli, R. E. Schmieder, and M. R. Weir, Salt: a perpetrator of hypertension target organ disease? Arch. Int. Med. 157, 2449–2452 (1997).
T. Kawasaki, E. S. Dlea, F. C. Porter, et al., The effect of high-sodium and low-sodium intake on blood pressure and other related variables in human subjects with idiopathic hypertension, Am. J. Med. 64, 193–198 (1978).
L. M. Resnick, J. H. Laragh, J. E. Sealey, et al., Deviate cations in essential hypertension, N. Engl. J. Med. 309, 888–891 (1983).
V. M. Campese, M. S. Romoff, D. Levitan, et al., Abnormal relationship between sodium intake and sympathetic nervous system activity in salt sensitive patients with essential hypertension, Kidney Int. 21, 371–378 (1992).
J. P. Midgley, A. Glenday, G. Matthew, et al., Effects of reduced dietary sodium on blood pressure, JAMA 275, 1590–1597 (1996).
T. Uzu, F. Kazembe, K. Ishikawa, et al., High sodium sensitivity implicates nocturnal hypertension in essential hypertension, Hypertension 28(Suppl. I), 139–143 (1996).
M. H. Alderman, S. Madhaven, H. Cohen, J. E. Sealey, and J. H. Laragh, Low urinary sodium is associated with greater risk of myorcardial infarction among treated hypertensive men, Hypertension 25, 1144–1152 (1995).
P. Elliot, J. Stamler, R. Nichels, et al., INTERSALT revisited, Br. Med. J. 312, 1249–1253 (1996).
A. Sharma, U. Schorr, and R. Distler, Insulin resistance in young salt-sensitive normotensive subjects, Hypertension 21, 273–279 (1993).
The Trials of Hypertension Prevention Collaborative Research Group, Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high normal blood pressure, Arch. Intern. Med. 157, 657–667 (1997).
G. Bunge, Textbook of Physiological and Pathological Chemistry, McGraw-Hill, New York (1902).
W. Thompson, and I. McQuerrie, Effect of various salts on carbohydrate metabolism and blood pressure in diabetic children, Proc. Soc. Exp. Biol. Med. 31, 907–909 (1934).
N. Sasak, T. Mitsuhash, and S. Fukushi, Effects of the ingestion of large amount of apples on blood pressure in farmers in Akita Prefecture, Igaku to Seibutsugaku 51, 103–105 (1959).
G. Krishna, and S. Kapoor, Potassium depletion exacerbates essential hypertension, Ann. Intern. Med. 115, 77–83 (1991).
G. Krishna, Effects of potassium intake on blood pressure, J. Am. Soc. Nephrol. 1, 43–52 (1990).
R. Watson, H. Landford, J. Abernethy, et al., Urinary electrolytes body weight in blood pressure, Hypertension 21(42), 93–98 (1980).
P. Whelton, J. He, J. Cutler, et al., Effects of oral potassium on blood pressure, JAMA 277, 1624–1632 (1997).
The Trials of Hypertension Prevention Collaborative Research Group, The effects of nonpharmacologic intervention on blood pressure of persons with high normal levels: results of the trials of Preventive Phase 1, JAMA 267, 1213–1220 (1992).
D. Wilson, D. Sica, and S. Miller, Effect of potassium on blood pressure in salt-sensitive and salt-resistant black adolescents, Hypertension 34(2), 181–186 (1999).
L. Tobian, J. Lange, K. Ulm, et al., Potassium reduces cerebral hemorrhage and death rate in hypertensive rats, even when blood pressure is not lowered, Hypertension 7(Suppl. 1), 110–114 (1985).
K. T. Khaw, and E. Barrett-Connor, Dietary potassium and stroke-associated mortality, N. Engl. J. Med. 316, 235–240 (1987).
F. Luft, M. Weinberger, C. Grim, and N. Fineberg, Effect of volume expansion and contraction on potassium homeostasis in normal and hypertensive humans, J. Am. Coll. Nutr. 5, 357–369 (1986).
H. Schroeder, and H. Perry, Antihypertensive effects of metal binding agents, J. Lab. Clin. Med. 46, 416–522 (1955).
O. Cope, Hyperparathyroidism, Am. J. Surg. 99, 394–403 (1960).
L. Neri, J. Mandel, and D. Hewitt, Relation between mortality and water hardness in Canada, Lancet 1, 931–934 (1972).
W. Harlan, A. Hull, R. Schmouder, et al., High blood pressure in older Americans: The First National Health and Nutrition Survey, Hypertension 6, 802–809 (1989).
P. Weidmann, S. Massry, J. Coburn, et al., Blood pressure effects of acute hypercalcemia, Ann. Intern. Med. 76, 741–745 (1978).
D. McCarron, Calcium metabolism and hypertension, Kidney Int. 35, 717–736 (1989).
K. Belizoon, and J. Villar, The relationship between calcium intake and edema-protenuria- and hypertension gestosis, Am. J. Clin. Nutr. 33, 2202–2210 (1980).
H. Bucher, G. Guyett, R. Cook, et al., Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia, JAMA 275, 1113–1118 (1996).
R. Lyle, C. Melby, G. Ayner, et al., Blood pressure and metabolic effects of calcium supplementation in normotensive white and black men, JAMA 257, 1772–1776 (1987).
L. Resnick, J. Nicholson, and J. Laragh, Calcium metabolism and the renin-aldosterone system in essential hypertension, J. Cardiovasc. Pharmacol. 7(Suppl. 6), S187-S193 (1985).
M. Weinberger, U. Wagner, and N. Fineberg, The blood pressure effects of calcium supplementation in humans of known salt responsiveness, Am. J. Hypertens. 6, 799–805 (1993).
J. Dwyer, K. Dwyer, R. Scribner, et al., Dietary calcium, calcium supplementation and blood pressure in African American adolescents, Am. J. Clin. Nutr. 68, 648–655 (1998).
L. Griffith, G. Guyatt, R. Cook, et al., The influence of dietary and nondietary calcium supplementation on blood pressure: an updated meta-analysis of randomized controlled trials, Am. J. Hypertens. 12, 84–92 (1999).
K. Blackfan, and B. Hamilton, Treatment of hypertensive diseases, Boston Med. Surg. J. 193, 617–621 (1925).
M. Stenchever, Magnesium, its relationship to obstetrics, Obstet. Gynec. Survey 16, 297–308 (1961).
M. Rubin, and M. Rappaport, The mode of action of magnesium in reducing the blood pressure of glomerular nephritis, Am. J. Med. Sci. 201(Suppl., 734–745 (1941).
D. Albert, Y. Morita, and L. Iseri, Serum magnesium and plasma sodium levels in essential vascular hypertension, Circulation 17(Pt. 2), 761–764 (1958).
B. T. Altura, and B. M. Altura, Cardiovascular actions of magnesium, Magnesium Bull. 9, 6–21 (1987).
R. Lim and W. Herzog, Magnesium for cardiac patients, Contemp. Intern. Med. 10, 6–9 (1998).
L. Resnick, J. Nicholson, and J. Laragh, Calcium metabolism and the renin-aldosterone system in essential hypertension, J. Cardiovasc. Pharmacol. 7(Suppl. 6), S187-S193 (1985).
C. Yang and H. Chiu, Calcium and magnesium in drinking water and the risk of death from hypertension, Am. J. Hypertens. 12, 894–899 (1999).
T. Fujita, Y. Ito, K. Ando, H. Noda, and E. Ogata, Attenuated vasodilator responses to Mg2+ in young patients with borderline hypertension, Circulation 82, 384–393 (1990).
M. Joffres, D. Reed, and K. Yano, Relationship of magnesium intake and other dietary factors to blood pressure, Am. J. Clin. Nutr. 45, 469–475 (1987).
P. Zemel, M. Zemel, M. Urberg, et al., Metabolic and hemodynamic effects on magnesium supplementation in patients with essential hypertension, Am. J. Clin. Nutr. 51, 665–669 (1990).
R. Rude, C. Mannoogian, L. Ehrlich, et al., Mechanics of blood pressure regulation by magnesium in man, Magnesium 8, 266–273 (1989).
K. Saito, K. Hattori, T. Omatsu, et al., Effects of oral magnesium on blood pressure and red cell sodium transport in patients receiving long-term thiazide diuretics for hypertension, Am. J. Hypertens. 1, 71S-74S (1988).
R. N. Stevenson, C. Keywood, A. Amadi, and D. J. Davies, Angiotensin converting enzyme inhibitors and conservation in patients with congestive heart failure, Br. Heart J. 66, 19–21 (1991).
H. Ventura, F. Malik, M. Mehra, D. Stapelton, and F. Smart, Mechanisms of hypertension in cardiac transplantation and the role of cyclosporine, Curr. Opin. Cardiol. 12, 375–381 (1997).
S. Vannini, B. Mazzola, L. Rodini, et al., Permanently reduced plasma ionized magnesium among recipients on cyclosporine, Transplant Int. 12, 244–249 (1999).
T. Nguyen and R. Steiner, A trial of magnesium supplementation in renal transplant recipients receiving cyclosporine, Transplant Proc. 30, 4317–4319 (1998).
A. Prasad and D. Oberfeas, Zinc, Ann. Intern. Med. 73, 631–636 (1970).
H. Perry, Jr., R. Masironi, and J. Miller, Concentrations of trace metals (Cd, Zn, Sc, Cu, Cr, and Fe) in organs (heart, kidney and liver) of subjects with myocardial infarction on hypertension, J. Trace Elements Exp. Med. 4, 109–128 (1991).
G. Vivoli, M. Bergomi, S. Roverti, M. Pinotti, and E. Caselgrands, Zinc, copper and zinc- or copper-dependent enzymes in human hypertension, Biol. Trace Element Res. 49, 97–103 (1995).
Y. Bakhle and A. Reynard, Characteristics of the angiotensin I converting enzyme from dog lung, Nature New Biol. 229, 187–189 (1971).
R. Hummelwright, N. Eickman, C. LuBien, K. Larch, and E. Solomen, Chemical and spectrographic studies of the binuclear copper active site of neurospora tyrosinase comparison to hemocyanins, J. Am. Chem. Soc. 102, 7339–7340 (1980).
P. Samuels, E. Main, M. Mennuti, and S. Gabbe, The origin of increased serum iron in pregnancy induced hypertension, Am. J. Obstet. Gynecol. 157, 721–725 (1987).
S. S. Entman, R. M. Moore, L. D. Richardson, and A. P. Killam, Elevated serum in toxemia of pregnancy, Am. J. Obstet. Gynecol. 143, 398–402 (1983).
M. Rabinowitz, D. Bellinger, A. Leviton, et al., Pregnancy hypertension, blood pressure during labor, and blood lead levels, Hypertension 10, 447–451 (1987).
W. Harlan, R. Landis, R. Schmouder, et al., Blood lead and blood pressure, JAMA 253, 530–534 (1985).
V. Batuman, E. Landy, J. Maesaka, et al., Contribution of lead to hypertension with renal impairment, N. Engl. J. Med. 309, 17–21 (1983).
A. Stern, Derivation of a target concentration of Ph in soil based on elevation of adult blood pressure, Risk Anal. 16, 201–210 (1996).
H. Sandstead, A. Michelakis, and T. Temple, Lead intoxication, Arch. Environ. Health 20, 356–363 (1970).
M. Amdur, J. Doull, and C. Klaasen, (eds.) Toxicology, Pergamon. New York, pp. 646–672 (1991).
S. Harvey, Heavy metals, in The Pharmacological Basis of Therapeutics, L. Goodman and A. Gilman, eds., MacMillan, New York, pp. 1598–1604 (1975).
Y. El-Sadik and A. El-Dakhakhny, Effects of exposure of workers to mercury at a sodium hydroxide producing plant, Am. Ind. Hyg. Assoc. J. 6, 705–710 (1970).
L. Shiryaev, On arterial hypertension in subjects exposed occupationally to the effect of metallic mercury, Gigiena Truda Professionalnye Zabalevaniia 15, 3–6 (1971).
M. Barni, et al., Resenti prospective sulla anatomica pathologica della intossicazione cronica da mercario, Fol Medica (Naples) 50, 641 (1967).
C. Huggins, K. Corcoran, J. Gordon, et al., Kenetics of the plasma and lung angiotensin I converting enzymes, Circ. Res. 27(Suppl. 1), I93-I108 (1970).
D. Roza and L. Berman, The pathophysiology of barium, J. Pharmacol. Exp. Ther. 177, 433–439 (1971).
C. Brenniman, T. Namekata, C. Kozolo, et al., Cardiovascular death rates in communities with elevated levels of barium in drinking water, Environ. Res. 20, 318–324 (1979).
R. Rubin, The role of calcium in the release of neurotransmitter substances and hormones, Pharmacol. Rev. 22, 398–428 (1970).
H. Perry, Jr., S. Koop, E. Perry, and W. Erlanger, Hypertension and associated cardiovascular abnormalities induced by chronic barium feedings, J. Toxicol. Environ. Health 28, 373–384 (1989).
H. Schroeder, Cadmium as a factor in hypertension, J. Chronic Dis. 18, 647–656 (1965).
H. Schroeder, A. Nason, and I. Tipton, Essential trace metals in man, J. Chronic Dis. 20, 769–770 (1967).
T. Syverson, T. Stray, G. Syverson, and J. Opstad, Cadmium and zinc in human liver and kidney, Scand. J. Clin. Lab. Invest. 36, 251–256 (1976).
J. Morgan, Tissue cadmium concentration in men, Arch. Intern. Med. 123, 405–408 (1969).
H. Perry, Jr. and M. Erlander, Metal-induced hypertension following chronic feeding of low doses of cadmium and mercury, J. Lab. Clin. Med. 83, 541–547 (1974).
H. Perry, Jr. and M. Erlander, Reversal of cadmium-induced hypertension by d-myoinositol-1,2,6-trisphosphate, J. Toxicol. Environ. Health 28, 151–159 (1999).
World Health Organization, Environmental Health Criteria. Volume 18 Arsenic, World Health Organization, Geneva, pp. 43–102 (1981).
L. Goodman and A. Gilman. The Pharmacological Basis of Therapeutics, Pergamon, New York, pp. 1602 (1990).
C. Chen, Y. Hsuch, M. Lai, et al., Increased prevalence of hypertension and long-term arsenic exposure, Hypertension 25(1), 53–60 (1995).
B. Upshaw, and J. Clayborn, Mechanical arsenic poisoning, South. Med. J. 88, 892 (1995).
D. Reed, J. Crawley, S. Faro, et al., Thallotoxicosis acute manifestatious and sequelae, JAMA 183, 480–490 (1969).
W. Bank, D. Pleasure, K. Suziki, et al., Thallium poisoning, Arch. Neurol. 26, 456–464 (1972).
K. Stark, A. Burger, and H. Schummann, Thallium and Brenzcateckinaminstoffwechsel: thallium and catacholamine metabolism, Naunym Schmiedeberg Arch. Pharm. 264, 310–311 (1969).
L. Hanlon, M. Romaine III, F. Gilroy, and J. Dertrick, Lithium chloride as a substitute for sodium chloride in the diet, JAMA 139, 688–692 (1949).
A. Corcoran, R. Taylor, and I. Page, Lithium poisoning from the use of salt substitutes, JAMA 139, 685–692 (1949).
H. Hansen, and A. Amdisen, Lithium intoxication, Q. J. Med. 47, 123–144 (1978).
J. Michaeli, D. Bentshay, R. Kidron, and H. Dasberg, Severe hypertension and lithium intoxication, JAMA 251, 1680 (1984).
P. Zachariah and A. Rosenbaum, Stabilization of high blood pressure with tricyclic antidepressants and lithium combinations in hypertensive patients, Mayo Clin. Proc. 57, 625–628 (1982).
J. Schildkraut, S. Schanberg, and I. Kopia, The effects of lithium ion on H3-norepinephrine, Life Sci. 5, 1479–1483 (1966).
C. Wilbur, Toxicology of selenium, Clin. Toxicol. 17, 198 (1980).
X. Chen, G. Yang, and J. Chen, Studies on the relationship of selenium and Keshan disease, Biol. Trace Element Res. 2, 91–107 (1980).
V. Lavine, Biological studies of selenium, Ann. NY Acad. Sci. 26, 385–394 (1915).
J. Tuomilehto, Nutrition related determinants of blood pressure, Prev. Med. 14, 413–427 (1985).
Y. Deguchi, Relationships between blood selenium concentrations and grasping power, blood pressure, hematocrit and hemoglobin concentrations in Japanese rural residents, Jpn. J. Hyg. 39, 924–929 (1985).
L. Han and S. Zhou, Selenium supplementtion in the prevention of pregnancy induced hypertension, Chin. Med. J. 107, 870–871 (1994).
H. Perry, Jr., R. Masironi, Q. Parr, and J. Miller, Concentrations of trace metals (Cd, Zn, Se, Cu, Cr and Fe) in organs (heart, kidney and liver) of subjects with myocardial infarction or hypertension: WHO/AEA myocardial infarction and hypertension on autopsy study, J. Trace Elements Exp. Med. 4, 109–128. (1991).
H. Hilse, P. Ochme, W. Krause, and K. Hecht, Effect of sodium selenite on experimental hypertension in rat, Acta Physiol. Pharmacol. Bulg. 5, 47–50 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Loyke, H.F. Effects of elements in human blood pressure control. Biol Trace Elem Res 85, 193–209 (2002). https://doi.org/10.1385/BTER:85:3:193
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/BTER:85:3:193